Synopsys, Inc. (SNPS) Guidance & Earnings Results
On 2026-08-26 Synopsys, Inc. raised guidance: "FY2026 revenue raised to $9.69-9.74B; non-GAAP EPS $15.04-15.10; Q4 FY2026 revenue $2.53-2.58B; non-GAAP EPS $4.10-4.16; operating cash flow ~$2.8B; free cash flow ~$2.6B; capex ~$225M; non-GAAP operating margin…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
SNPSSynopsys, Inc.Follow SNPS — free
—
Price chart with a free account
- Market cap
- 82.4B
- P/E TTM
- 76.9
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 8 Dec, in 45 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 26 Aug 26 | Raised | FY2026 revenue raised to $9.69-9.74B; non-GAAP EPS $15.04-15.10; Q4 FY2026 revenue $2.53-2.58B; non-GAAP EPS $4.10-4.16; operating cash flow ~$2.8B; free cash flow ~$2.6B; capex ~$225M; non-GAAP operating margin ~41.5% · full year |
| 27 May 26 | Raised | Revenue guidance raised to $9.665B midpoint; non-GAAP EPS raised to $14.76 midpoint · full year |
| 25 Feb 26 | Reaffirmed | Full-year revenue midpoint $9.61B; Q2 FY2026 revenue $2.225B-$2.275B; FY2026 non-GAAP EPS $14.38-$14.46 · full year |
| 10 Dec 25 | Raised | FY2026 revenue guidance $9.56B-$9.66B, non-GAAP EPS $14.32-$14.40 · full year |
| 9 Sep 25 | Reaffirmed | FY2025 revenue $7.03B-$7.06B; non-GAAP EPS $12.76-$12.80; FCF ~$950M · full year |
Synopsys, Inc. — questions
- What guidance did Synopsys, Inc. give?
- On 2026-08-26: "FY2026 revenue raised to $9.69-9.74B; non-GAAP EPS $15.04-15.10; Q4 FY2026 revenue $2.53-2.58B; non-GAAP EPS $4.10-4.16; operating cash flow ~$2.8B; free cash flow ~$2.6B; capex ~$225M; non-GAAP operating margin ~41.5%"
- When does Synopsys, Inc. report earnings?
- Synopsys, Inc.'s next earnings report is expected on 2026-12-08.
Every figure on this page comes from Synopsys, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.